Fay H Cafferty - JoVE Visualize

Showing results (11-20 of 28) with videos related to

Pageof 3

Sort By:

American Journal of Epidemiology|May 28, 2008

Correcting for lead time and length bias in estimating the effect of screen detection on cancer survivalStephen W Duffy, Iris D Nagtegaal, Matthew Wallis, et al.

Trials|May 11, 2021

Accessing routinely collected health data to improve clinical trials: recent experience of accessArchie Macnair, Sharon B Love, Macey L Murray, et al.

Contemporary Clinical Trials|October 30, 2016

ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumoursChristopher Coyle, Fay H Cafferty, Samuel Rowley, et al.

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 1, 2026

Factors associated with arm swelling in patients undergoing surgery and radiotherapy for breast cancer within the FAST-Forward trial nodal sub-studySaranya Ravindra, Fay H Cafferty, Emma Harris, et al.

Clinical Trials (London, England)|August 24, 2017

Testing many treatments within a single protocol over 10 years at MRC Clinical Trials Unit at UCL: Multi-arm, multi-stage platform, umbrella and basket protocolsMahesh Kb Parmar, Matthew R Sydes, Fay H Cafferty, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2012

Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening scheduleAdam N Rosenthal, Lindsay Fraser, Ranjit Manchanda, et al.

The Lancet. Oncology|March 8, 2013

Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: the randomised, phase 2 MRC PATCH trial (PR09)Ruth E Langley, Fay H Cafferty, Abdulla A Alhasso, et al.

JAMA Oncology|June 21, 2019

Safety and Efficacy of the Addition of Lapatinib to Perioperative Chemotherapy for Resectable HER2-Positive Gastroesophageal Adenocarcinoma: A Randomized Phase 2 Clinical TrialElizabeth C Smyth, Samuel Rowley, Fay H Cafferty, et al.

The Lancet. Oncology|June 14, 2025

Partial-breast radiotherapy after breast conservation surgery for women with early breast cancer (UK IMPORT LOW): 10-year outcomes from a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trialAnna M Kirby, Laura Finneran, Clare L Griffin, et al.

Clinical and Translational Radiation Oncology|February 24, 2026

PACE-NODES: A phase III randomised trial of 5 fraction prostate stereotactic body radiotherapy (SBRT) versus 5 fraction prostate and pelvic nodal SBRTAngela Pathmanathan, Suneil Jain, John Staffurth, et al.

Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:

Pageof 3

American Journal of Epidemiology|May 28, 2008

Correcting for lead time and length bias in estimating the effect of screen detection on cancer survivalStephen W Duffy, Iris D Nagtegaal, Matthew Wallis, et al.

Trials|May 11, 2021

Accessing routinely collected health data to improve clinical trials: recent experience of accessArchie Macnair, Sharon B Love, Macey L Murray, et al.

Contemporary Clinical Trials|October 30, 2016

ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumoursChristopher Coyle, Fay H Cafferty, Samuel Rowley, et al.

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 1, 2026

Factors associated with arm swelling in patients undergoing surgery and radiotherapy for breast cancer within the FAST-Forward trial nodal sub-studySaranya Ravindra, Fay H Cafferty, Emma Harris, et al.

Clinical Trials (London, England)|August 24, 2017

Testing many treatments within a single protocol over 10 years at MRC Clinical Trials Unit at UCL: Multi-arm, multi-stage platform, umbrella and basket protocolsMahesh Kb Parmar, Matthew R Sydes, Fay H Cafferty, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2012

Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening scheduleAdam N Rosenthal, Lindsay Fraser, Ranjit Manchanda, et al.

The Lancet. Oncology|March 8, 2013

Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: the randomised, phase 2 MRC PATCH trial (PR09)Ruth E Langley, Fay H Cafferty, Abdulla A Alhasso, et al.

JAMA Oncology|June 21, 2019

Safety and Efficacy of the Addition of Lapatinib to Perioperative Chemotherapy for Resectable HER2-Positive Gastroesophageal Adenocarcinoma: A Randomized Phase 2 Clinical TrialElizabeth C Smyth, Samuel Rowley, Fay H Cafferty, et al.

The Lancet. Oncology|June 14, 2025

Partial-breast radiotherapy after breast conservation surgery for women with early breast cancer (UK IMPORT LOW): 10-year outcomes from a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trialAnna M Kirby, Laura Finneran, Clare L Griffin, et al.

Clinical and Translational Radiation Oncology|February 24, 2026

PACE-NODES: A phase III randomised trial of 5 fraction prostate stereotactic body radiotherapy (SBRT) versus 5 fraction prostate and pelvic nodal SBRTAngela Pathmanathan, Suneil Jain, John Staffurth, et al.

Pageof 3